A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)

Clinical trial NCT05094336 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05094336
Sponsor: Amgen
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced MTAP-null Solid Tumors

Start date: 2022-02-01
Primary completion: 2026-11-30
Enrollment: 329

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.